Trial Profile

A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
Indications Postoperative pain
Focus Therapeutic Use
Sponsors Heron Therapeutics

Most Recent Events

13 Sep 2023 Number of treatment arms have been increased from 9 to 12 by the addition of separate dose levels of bupivacaine/meloxicam combination and an active comparator arm.
26 Sep 2017 Status changed from recruiting to completed.
31 Mar 2017 Planned number of patients changed from 500 to 550.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com